Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) - Total Liabilities
Based on the latest financial reports, Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) has total liabilities worth CN¥1.27 Billion CNY (≈ $185.81 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Shanghai Haishun New Pharmaceutical Pack long-term investment intensity to see how much of total assets are deployed in long-term investments.
Shanghai Haishun New Pharmaceutical Packaging Co Ltd - Total Liabilities Trend (2011–2025)
This chart illustrates how Shanghai Haishun New Pharmaceutical Packaging Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 300501 asset base.
Shanghai Haishun New Pharmaceutical Packaging Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shanghai Haishun New Pharmaceutical Packaging Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Crawford & Company
NYSE:CRD-A
|
USA | $597.19 Million |
|
Zhejiang XinNong Chemical Co Ltd Class A
SHE:002942
|
China | CN¥451.97 Million |
|
Ashiana Housing Limited
NSE:ASHIANA
|
India | Rs36.96 Billion |
|
ShenZhen V&T Technologies Co Ltd
SHE:300484
|
China | CN¥225.97 Million |
|
Shanghai Rychen Technologies Co. Ltd. A
SHE:301273
|
China | CN¥336.55 Million |
|
Marcopolo S.A
SA:POMO3
|
Brazil | R$5.83 Billion |
|
Open Lending Corp
NASDAQ:LPRO
|
USA | $155.77 Million |
|
AVIT Ltd
SHE:300264
|
China | CN¥201.71 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Shanghai Haishun New Pharmaceutical Packaging Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 300501 equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.82 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.44 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Haishun New Pharmaceutical Packaging Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Haishun New Pharmaceutical Packaging Co Ltd (2011–2025)
The table below shows the annual total liabilities of Shanghai Haishun New Pharmaceutical Packaging Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.19 Billion ≈ $173.98 Million |
+12.40% |
| 2024-12-31 | CN¥1.06 Billion ≈ $154.79 Million |
-0.56% |
| 2023-12-31 | CN¥1.06 Billion ≈ $155.65 Million |
+69.98% |
| 2022-12-31 | CN¥625.80 Million ≈ $91.57 Million |
-7.77% |
| 2021-12-31 | CN¥678.55 Million ≈ $99.29 Million |
+28.25% |
| 2020-12-31 | CN¥529.08 Million ≈ $77.42 Million |
+11.98% |
| 2019-12-31 | CN¥472.49 Million ≈ $69.14 Million |
+107.56% |
| 2018-12-31 | CN¥227.64 Million ≈ $33.31 Million |
+198.80% |
| 2017-12-31 | CN¥76.19 Million ≈ $11.15 Million |
-14.85% |
| 2016-12-31 | CN¥89.47 Million ≈ $13.09 Million |
+31.74% |
| 2015-12-31 | CN¥67.91 Million ≈ $9.94 Million |
+21.48% |
| 2014-12-31 | CN¥55.90 Million ≈ $8.18 Million |
-8.70% |
| 2013-12-31 | CN¥61.23 Million ≈ $8.96 Million |
+10.41% |
| 2012-12-31 | CN¥55.46 Million ≈ $8.12 Million |
-1.65% |
| 2011-12-31 | CN¥56.39 Million ≈ $8.25 Million |
-- |
About Shanghai Haishun New Pharmaceutical Packaging Co Ltd
HySum Flexibles Global, Inc. engages in the manufacture, sale, and export of pharmaceutical packaging products in China and internationally. The company offers pharmaceutical packaging products, including cold-form, tropical blister foil, PVC/Aclar sheets, PTP lidding, hipack child-resistant packaging, hipack AL/PE strip packs, hipack complex laminated flexible films, lamination foil and pouch, c… Read more